Abstract.
A Hurthle cell tumor (oncocytoma) of the thyroid presented as a hypermetabolic focus in a fluorodeoxyglucose positron emission tomography (FDG PET) study which was performed as staging procedure in a patient with malignant melanoma. This finding led to the initial diagnosis of a metastasis. In contrast, multiple liver metastases, seen on MRI and sonography, did not show any increased FDG uptake. Cytology results of one liver mass confirmed a melanoma metastasis, and of the neck mass, a Hurthle cell tumor. The Hurthle cell tumor was, based on clinical evidence, thought to be benign. This is the first description of a FDG PET-positive benign Hurthle cell tumor, with FDG PET-negative liver metastases of a malignant melanoma, in the same patient.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 8 June 1998; Accepted 3 August 1998
Rights and permissions
About this article
Cite this article
Wiesner, W., Engel, H., von Schulthess, G. et al. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive Hurthle cell tumor of the thyroid. Eur Radiol 9, 975–978 (1999). https://doi.org/10.1007/s003300050779
Issue Date:
DOI: https://doi.org/10.1007/s003300050779